Cardarine, also known as GW-501516, is not a Selective Androgen Receptor Modulator (SARM), but rather a Peroxisome Proliferator-Activated Receptor delta (PPAR-delta) agonist. It is a synthetic drug that was initially developed for its potential cardiovascular and metabolic benefits.
Cardarine works by activating PPAR-delta, a type of nuclear receptor that plays a role in various physiological processes, including lipid metabolism and energy expenditure. As a result, Cardarine is believed to enhance endurance, improve fat metabolism, and increase overall physical performance.
Cardarine, also known as GW-501516, is not a Selective Androgen Receptor Modulator (SARM), but rather a Peroxisome Proliferator-Activated Receptor delta (PPAR-delta) agonist. It is a synthetic drug that was initially developed for its potential cardiovascular and metabolic benefits.
Cardarine works by activating PPAR-delta, a type of nuclear receptor that plays a role in various physiological processes, including lipid metabolism and energy expenditure. As a result, Cardarine is believed to enhance endurance, improve fat metabolism, and increase overall physical performance.
It's important to note that the use of Cardarine has been a subject of controversy and concern. As of my last knowledge update in January 2022, there is limited research on its long-term safety and potential side effects. Additionally, Cardarine is not approved for medical use in many countries, and its use in athletic and bodybuilding circles raises ethical and legal considerations.
If you are considering the use of Cardarine or any similar compound, it is crucial to consult with a healthcare professional. Self-administration without proper guidance can pose risks to health, and it's essential to stay informed about the latest research and regulatory updates in this field.
| Description | GW501516, also known as GW-1516 or cardarine and endurobol, is a peroxisome proliferator-activated receptor delta (PPAR-δ) agonist. Activation of the receptor will increase fat-burning capacity and muscle production, as it changes the body's fuel preference from glucose to lipids. |
| Description | Peroxisome proliferator- |
| History | GW501516, also known as Cardarine, was originally discovered in the early 1990s during a research collaboration between two large pharmaceutical companies. The initial proposed use was for the treatment of hyperlipidemia (elevated fats in the blood), though later studies looked at its effectiveness for treating obesity, diabetes, and cardiovascular disease. |
| Uses | GW501516 has been used to study its effect on mutation-driven colorectal tumorigenesis and tumor invasion using mouse model. |
| Uses | An experimental drug meant to control lipids and increase the level of HDL, or good cholesterol, in the bloodstream. A cell-permeable, thiazolyl compound that acts as a potent, high affinity, PPARd agonist. Exhibits selectivity for PPARd compared t |
